AMZ0026 -  Amazon Biotech's HIV drug. phase I/II clinical studies have been approved by the FDA and are to be initiated shortly.

AMZ0026-H - AMZ0026's sister-formulation; contains an additional anti-viral botanical component. Foreign studies are in the planning stage and an IND is being prepared for submission to the FDA.

AZC0027 - Amazon Biotech's breast-cancer drug formulation.